The session was moderated by Rosanna Tarricone, PhD, Professor, Centre for Research on Health and Social Care Management, Bocconi University, Milan, Italy. Speakers for the session included:- Michael F. Drummond, MCom, DPhil, Professor of Health Economics, Centre for Health Economics, University of York, Heslington, York, UK - Mirella Marlow, MBA, MA, Programme Director, Devices and Diagnostics Systems, National Institute for Health and Clinical Excellence (NICE), London, UK- Adrian Griffin, MSc, Vice President, HTA and Reimbursement Policy, Johnson & Johnson, High Wycombe, UK
This issue panel examined how incentives could be utilized to increase the range and quality of effectiveness research of medical devices. Speakers noted that medical devices often gain market authorization with significantly less clinical effectiveness evidence than other health technologies, such as pharmaceuticals, because of the different legal requirements for approval of medical devices. The panel also remarked that post-market effectiveness research may actually be more important for medical devices than pharmaceuticals since the performance of the device often depends on the interaction with the user.
Additional information on the ISPOR 19th Annual European Congress can be found here. Released presentations from the congress can be found here. Interested parties can follow news and developments from the conference on social media using the hashtag #ISPORVienna.
###
ABOUT ISPORThe International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that promotes health economics and outcomes research excellence to improve decision making for health globally. Web: www.ISPOR.org | LinkedIn: www.bit.ly/ISPOR-IN | Twitter: www.bit.ly/ISPOR-T (@ISPORorg) | YouTube: www.bit.ly/ISPOR-YT |Facebook: www.bit.ly/ISPOR-FB
RSS